The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Sahu, A., Kasoju, N., & Bora, U. (2008) · Biomacromolecules · doi:10.1021/bm800683f · Cited by 548
Preparation of Hierarchical Hollow CaCO3 Particles and the Application as Anticancer Drug Carrier
Wei, W., Ma, G.-H., Hu, G., Yu, D., Mcleish, T., Su, Z.-G., & Shen, Z.-Y. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8039585 · Cited by 455
Uptake of FITC-Chitosan Nanoparticles by A549 Cells
Huang, M., Ma, Z., Khor, E., & Lim, L.-Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1020404615898 · Cited by 390
Silk fibroin nanoparticles for cellular uptake and control release
Kundu, J., Chung, Y.-I., Kim, Y. H., Tae, G., & Kundu, S. C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.052 · Cited by 336
Self-citationTargeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
Silk fibroin/polyacrylamide semi-interpenetrating network hydrogels for controlled drug release
Mandal, B. B., Kapoor, S., & Kundu, S. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.040 · Cited by 300
Self-citationWeng, K. C., Noble, C. O., Papahadjopoulos-Sternberg, B., Chen, F. F., Drummond, D. C., Kirpotin, D. B., Wang, D., Hom, Y. K., Hann, B., & Park, J. W. (2008) · Nano Letters · doi:10.1021/nl801488u · Cited by 273
Kester, M., Heakal, Y., Fox, T., Sharma, A., Robertson, G. P., Morgan, T. T., Altinoğlu, E. İ., Tabaković, A., Parette, M. R., Rouse, S. M., et al. (2008) · Nano Letters · doi:10.1021/nl802098g · Cited by 272
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer
Xiao, K., Luo, J., Fowler, W. L., Li, Y., Lee, J. S., Xing, L., Cheng, R. H., Wang, L., & Lam, K. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.015 · Cited by 238
Rosenholm, J. M., Peuhu, E., Eriksson, J. E., Sahlgren, C., & Lindén, M. (2009) · Nano Letters · doi:10.1021/nl901589y · Cited by 218
Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism
Patel, M. I., Subbaramaiah, K., Du, B., Chang, M., Yang, P., Newman, R. A., Cordon-Cardo, C., Thaler, H. T., & Dannenberg, A. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1877 · Cited by 215
Cellular Uptake and Cytotoxicity of Silica Nanotubes
Nan, A., Bai, X., Son, S. J., Lee, S. B., & Ghandehari, H. (2008) · Nano Letters · doi:10.1021/nl0802741 · Cited by 212
Mandal, B. B., & Kundu, S. C. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/35/355101 · Cited by 158
Self-citationPharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats
Paulson, S. K., Zhang, J. Y., Breau, A. P., Hribar, J. D., Liu, N. W. K., Jessen, S. M., Lawal, Y. M., Cogburn, J. N., Gresk, C. J., Markos, C. S., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15094-5 · Cited by 151
Yokoi, K., Thaker, P. H., Yazıcı, S., Rebhun, R. B., Nam, D., He, J., Kim, S.-J., Abbruzzese, J. L., Hamilton, S. R., & Fidler, I. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3700 · Cited by 143
Chun, C., Lee, S. M., Kim, C. W., Hong, K.-Y., Kim, S. Y., Yang, H. K., & Song, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.031 · Cited by 123
Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers
He, M., Zhao, Z., Yin, L., Tang, C., & Yin, C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.02.012 · Cited by 113
Lv, G., He, F., Wang, X., Gao, F., Zhang, G., Wang, T., Jiang, H., Wu, C., Guo, D., Li, X., et al. (2008) · Langmuir · doi:10.1021/la702845s · Cited by 112
Hiremath, P. S., Soppimath, K. S., & Betageri, G. V. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.008 · Cited by 109
Qu, G., Yao, Z., Zhang, C., Wu, X., & Ping, Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.01.004 · Cited by 103
A Nanoemulsion Formulation of Tamoxifen Increases Its Efficacy in a Breast Cancer Cell Line
Tagne, J., Kakumanu, S., Ortiz, D., Shea, T. B., & Nicolosi, R. J. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700091j · Cited by 102
Tan, M. L., Friedhuber, A. M., Dunstan, D. E., Choong, P., & Dass, C. R. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.069 · Cited by 75
Pham, H. H., Luo, P., Génin, F., & Dash, A. K. (2002) · AAPS PharmSciTech · doi:10.1208/pt030101 · Cited by 75
Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity
Jung, S. H., Jung, S. H., Seong, H., Cho, S. H., Jeong, K.-S., & Shin, B. C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.08.002 · Cited by 68
Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate
Guggi, D., Langoth, N., Hoffer, M. H., Wirth, M., & Bernkop‐Schnürch, A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.016 · Cited by 66
Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects
Mohammed, S. I., Dhawan, D., Abraham, S., Snyder, P. W., Waters, D. J., Craig, B. Α., Lu, M., Wu, L., Zheng, R., Stewart, J. C., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0117 · Cited by 55
Antibiotic delivery system using nano‐hydroxyapatite/chitosan bone cement consisting of berberine
Zou, Q., Li, Y., Zhang, L., Zuo, Y., Li, J., & Li, J. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32199 · Cited by 54
Sasaki, T., Kitadai, Y., Nakamura, T., Kim, J.-S., Tsan, R. Z., Kuwai, T., Langley, R. R., Fan, D., Kim, S.-J., & Fidler, I. J. (2007) · Neoplasia · doi:10.1593/neo.07667 · Cited by 46
Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy
Kuwai, T., Nakamura, T., Sasaki, T., Kitadai, Y., Kim, J.-S., Langley, R. R., Fan, D., Wang, X., Do, K.-A., Kim, S.-J., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9153-7 · Cited by 44
Tuřánek, J., Wang, X., Knötigová, P. T., Koudelka, Š., Dong, L., Vrublová, E., Mahdavian, E., Procházka, L., Sangsura, S., Vacek, A., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.01.027 · Cited by 42
Katanasaka, Y., Ida, T., Asai, T., Shimizu, K., Koizumi, F., Maeda, N., Baba, K., & Oku, N. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.009 · Cited by 40
Younes, M. N., Yazici, Y. D., Kim, S., Jasser, S. A., El‐Naggar, A. K., & Myers, J. N. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0793 · Cited by 35
Auman, J. T., Church, R. D., Lee, S., Watson, M. A., Fleshman, J. W., & McLeod, H. L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.05.010 · Cited by 31
Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells
Zhang, L., Gao, H., Chen, L., Wu, B., Zheng, Y., Liao, R., Jiang, Y., & He, F. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.024 · Cited by 25
Cited by
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
A review on chitosan and its nanocomposites in drug delivery
Ali, A., & Ahmed, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.078 · Cited by 1,127
Scaffold: A Novel Carrier for Cell and Drug Delivery
Garg, T., Singh, O., Arora, S., & Murthy, R. S. R. (2012) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v29.i1.10 · Cited by 549
Versatile Types of Organic/Inorganic Nanohybrids: From Strategic Design to Biomedical Applications
Zhao, N., Yan, L., Zhao, X., Chen, X., Li, A., Zheng, D., Zhou, X., Dai, X., & Xu, F.-J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00401 · Cited by 429
Synthesis, Bioapplications, and Toxicity Evaluation of Chitosan-Based Nanoparticles
Rizeq, B. R., Younes, N. N., Rasool, K., & Nasrallah, G. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225776 · Cited by 358
Metadata
- Authors
- Venkatesan, P., Puvvada, N., Dash, R., Prashanth Kumar, B. N., Sarkar, D., Azab, B., Pathak, A., Kundu, S. C., Fisher, P. B., & Mandal, M.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 32
- Issue
- 15
- Pages
- 3794-3806
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2084831685
- Cited by
- 262
- References
- 36
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.